Search clinical trials for: E2020-Donepezil hydrochloride

Total 7618 results

Eisai Co., Ltd.

Completed

A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)

Dementia With Lewy Bodies (DLB)

Japan
Eisai Co., Ltd.

Completed

A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease

Dementia Associated With Cerebrovascular Disease

Korea, Republic of
Eisai Co., Ltd.

Completed

A Double-blind, Placebo-controlled Comparative Study and Open-label Extension Study to Confirm the Efficacy and Safety of E2020 in Subjects With Down Syndrome Having Regression Symptoms and Disabled Activities of Daily Living.

Down Syndrome

Japan
Eisai Inc.
Pfizer

Completed

Neural Correlates In Mild Alzheimer's Disease

Alzheimer's Disease

United States
Eisai Co., Ltd.

Completed

A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase

Dementia With Lewy Bodies (DLB)

Japan
Eisai Inc.
Pfizer

Terminated

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10

Cognitive Dysfunction | Down Syndrome

United States
Eisai Inc.
Pfizer

Terminated

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17

Cognitive Dysfunction | Down Syndrome

United States
Eisai Inc.

Completed

An Evaluation Of The Efficacy And Safety Of Donepezil Hydrochloride (E2020) In Migraine Prophylaxis

Migraine Headache

United States
Teva Pharmaceuticals USA

Completed

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions

Healthy

United States
Eisai Inc.

Completed

A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment

Mild Cognitive Impairment

United States
Eisai Inc.

Completed

A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia

Alzheimer's Type Dementia

Japan
Eisai Inc.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2027 in Healthy Subjects

Healthy Subjects

United States
Eisai Co., Ltd.

Completed

Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease

Alzheimer's Type Dementia

Japan
Eisai Co., Ltd.

Completed

A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)

Lewy Body Disease | Dementia, Lewy Body

Japan
Eisai Limited

Completed

A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease

Alzheimer's Type Dementia

China
Eisai Co., Ltd.

Completed

A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies

Dementia With Lewy Bodies (DLB)
Teva Pharmaceuticals USA

Completed

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.

Healthy

United States
Eisai Inc.
Eisai Limited

Completed

Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease

Alzheimer's Disease

United States
Stanford University

Completed

An Open-Label Trial of Donepezil in Fragile X Syndrome

Fragile X Syndrome

United States
Eisai Co., Ltd.

Completed

A Phase 1 Study of E2022 Tape Formulation for Different Application Sites and Intervals in Japanese Healthy Elderly Males

Healthy Elderly Male

Japan
Eisai Inc.

Completed

A Study of E2027 in Participants With Dementia With Lewy Bodies (DLB) or Parkinson's Disease Dementia (PDD) With or Without Amyloid Copathology

Parkinson Disease | Lewy Body Disease

United States, Canada
Eisai Inc.

Completed

A Study to Determine the Metabolism and Elimination of [14C]E2027 in Healthy Male Participants

Dementias With Lewy Bodies

United States
Eisai Co., Ltd.

Completed

A Study of E2022 Tape Formulation (Overlay-integrated E2022 18 mg Tape Formulation) for Different Application Sites and Intervals in Japanese Healthy Elderly Males

Healthy Subjects

Japan
Eisai Co., Ltd.

Completed

E2022 Patch Formulation Single Dose Phase I Study

Japanese Healthy Male Adult Volunteers

Japan
Eisai Inc.

Completed

Study to Assess the Safety, Tolerability, Pharmacokinetics of E2027 in Healthy Adult and Elderly Subjects, and the Pharmacodynamics in Healthy Adult Subjects

Healthy Participants

United States
Shanghai Synergy Pharmaceutical Sciences Co., Ltd.

Completed

Safety and Pharmacokinetic of Donepezil Pamoate in Healthy Subjects

AD

China
Eisai Inc.

Completed

Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia

Parkinson's Disease | Dementia

United Kingdom
University Hospital, Lille
Innovative Medicines Initiative

Completed

Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development (PharmacogWP3)

Alzheimer Disease | Battery

France
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

The Effect of Donepezil in Radiotherapy-related Cognitive Impairment.

Cognitive Impairment | Radiation Injuries

China
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).

Dementia With Lewy Body Disease

Japan
Eisai Korea Inc.

Completed

Alzheimer's Disease Long-term Follow-up Study (ALF Study)

Alzheimer's Disease

Korea, Republic of
Eisai Inc.
Pfizer

Completed

Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease

Dementia | Alzheimer's Disease

United States, Canada, United Kingdom, Australia, France, Ireland
Eisai Co., Ltd.

Completed

A Bioequivalence Study Comparing Improved Versus Current Orally Disintegrating E2020 10 mg Tablet in Healthy Japanese Adult Males

Healthy Adult

Japan
Eisai Inc.
Eisai Limited

Completed

Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment

Attention Impairment

United States, Netherlands, France, Spain, United Kingdom, Germany, Argentina, Canada, Australia, Chile
Eisai Inc.
Pfizer

Withdrawn

Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease

Severe Alzheimer's Disease

United States
Central South University

Unknown

A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia

Schizophrenia | Impaired Cognition

China
Eisai Limited

Completed

A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020

Alzheimer Disease

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-

Alzheimer's Disease

Japan
Eisai Co., Ltd.

Completed

A Bioequivalence Study of Film-coated Tablet and Dry Syrup 1% Form for E2020 in Healthy Japanese Adult Males

Healthy Adult

Japan
Eisai Inc.

Completed

Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease

Dementia, Vascular

United States
Eisai Inc.
Pfizer

Completed

The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)

Memory Loss

United States
Shanghai University of Traditional Chinese Medicine
Huashan Hospital; Shanghai Mental Health Center

Recruiting

Clinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's Disease

Cognitive Impairment | Alzheimer Disease

China
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

Brain Tumors | Metastatic Disease

United States
Eisai Korea Inc.

Terminated

Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients

Alzheimer's Disease

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults

Healthy

Korea, Republic of
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceutical Limited's Donepezil Hydrochloride Tablets Under Fed Conditions

Healthy

India
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study for Donepezil Hydrochloride 10 mg Tablets Under Fasting Condition

Healthy

India
Fundació Institut de Recerca de l'Hospital de la...

Not yet recruiting

Randomized Clinical Trial of Donepezil for the Treatment of Mild Cognitive Impairment in Parkinson's Disease

Parkinson Disease | Mild Cognitive Impairment
Baylor College of Medicine
Albert Einstein Healthcare Network; Indiana University; Spaulding Rehabilitation... and other collaborators

Active, not recruiting

Multicenter Evaluation of Memory Remediation After TBI With Donepezil (MEMRI-TBI-D)

Traumatic Brain Injury | Memory Deficits

United States
Eisai Inc.
Eisai Co., Ltd.

Completed

Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia

Vascular Dementia

Philippines

3

Subscribe